I am new here at agora.com, but as far as RBM goes the board at stockhouse has the best info. I am hold a lot of RBM and think it will do very well but may take another year for revenues to really build. The company just got the FDA approval for fluA + B and throught 3M world wide distribution will begin before the next flu season. Still waiting for approval of congestive heart failure ( NtProBNP) and the announcement of the cardiac distribution partner, this is holding the stock price back, I think most big inverstors have already positioned themselves in this stock,but the cardiac partner may take an equity position, share prices tend to lag when such deals are in the works.

Regards

~~ Dick